berberine has been researched along with nutlin-3a in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, SL; Akula, SM; Candido, S; Cervello, M; Cocco, L; Falzone, L; Follo, ML; Libra, M; Lombardi, P; Martelli, AM; McCubrey, JA; Montalto, G; Ratti, S; Steelman, LS | 1 |
1 other study(ies) available for berberine and nutlin-3a
| Article | Year |
|---|---|
Effects of the MDM2 inhibitor Nutlin-3a on sensitivity of pancreatic cancer cells to berberine and modified berberines in the presence and absence of WT-TP53.
Topics: Apoptosis; Berberine; Cell Line, Tumor; Humans; Imidazoles; Pancreatic Neoplasms; Piperazines; Proto-Oncogene Proteins c-mdm2; Signal Transduction; Tumor Suppressor Protein p53 | 2022 |